EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Modulation of host lung immunity in Pneumocystis pneumonia: a review of current concepts and future prospects for novel adjunctive immune-based therapies

Theodore J Kottom iD, Andrew H Limper

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf269 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Theodore J Kottom und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Diseases Research, Department of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, United St…. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Lung, Pneumocystis carinii, Immunotherapy. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumocystis jirovecii pneumonia remains a significant cause of mortality and morbidity in immunocompromised populations worldwide. Mortality rates range from 5% to 30% in HIV-positive individuals and 4% to 76% in those without HIV. Recognizing its public health impact, the World Health Organization (WHO) included Pneumocystis jirovecii in its 2022 “Fungal Priority Pathogens” list. In this review, we will summarize published findings over the last 14 years on the immunopathogenic mechanisms underlying Pneumocystis pneumonia–related lung injury and examine the potential for targeting these pathways in adjunctive immune modulation therapy. Notably, recent studies have identified promising immune-based interventions, including PD-1/PD-L1 blockade and IL-7 therapy, which may enhance pathogen clearance while controlling damaging inflammation. Additionally, small molecule inhibitors such as BRD5529 and ALW-II-41-27 have shown potential in reducing lung injury by modulating proinflammatory signaling pathways in Pneumocystis pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisLungPneumocystis cariniiImmunotherapyHumansAnimals

Stichwörter der Autor:innen

Pneumocystisimmunityinflammation

Autor:innen und Institutionen

  • Division of Thoracic Diseases Research, Department of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, United States.

ORCID-Profile: Theodore J Kottom

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Kottom, T. J., & Limper, A. H. (2025). Modulation of host lung immunity in Pneumocystis pneumonia: a review of current concepts and future prospects for novel adjunctive immune-based therapies. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf269

Vancouver

Kottom TJ, Limper AH. Modulation of host lung immunity in Pneumocystis pneumonia: a review of current concepts and future prospects for novel adjunctive immune-based therapies. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf269

BibTeX
@article{Kottom2025,
  author = {Kottom, Theodore J and Limper, Andrew H},
  title = {Modulation of host lung immunity in Pneumocystis pneumonia: a review of current concepts and future prospects for novel adjunctive immune-based therapies},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf269}
}
Kostenlos starten →